Composition:-
URSODEOXYCHOLIC ACID 450 MG TAB
Uses:-
Ursodeoxycholic acid (UDCA) 450 mg tablets are prescribed to treat various liver and gallbladder conditions. UDCA works by reducing the production of cholesterol in the liver and by helping dissolve cholesterol-based gallstones. It is commonly used to manage symptomatic gallstone disease, where it helps in the dissolution of gallstones and prevents the formation of new ones. Additionally, UDCA is effective in treating primary biliary cholangitis (PBC), an autoimmune liver disease affecting the bile ducts. By reducing the accumulation of harmful bile acids in the liver and protecting liver cells from damage, UDCA improves liver function and alleviates symptoms associated with these conditions.
Side Effects:-
While UDCA is generally well-tolerated, it may cause some side effects in certain individuals. Common side effects include diarrhea, nausea, vomiting, abdominal pain, indigestion, and headache. These side effects are usually mild and temporary, resolving as the body adjusts to the medication. In rare cases, UDCA may lead to allergic reactions or more severe adverse effects such as liver problems or pancreatitis. It is important to promptly report any unusual or persistent symptoms to a healthcare provider. Individuals with underlying medical conditions or those taking other medications should consult a healthcare professional before initiating UDCA therapy to minimize the risk of interactions and adverse effects.
Indication:-
UDCA 450 mg tablets are indicated for the treatment of symptomatic gallstone disease and primary biliary cholangitis (PBC). In individuals with gallstones, UDCA facilitates the dissolution of cholesterol-based stones and prevents their recurrence. For patients with PBC, UDCA slows down the progression of the disease, improves liver function, and relieves symptoms such as fatigue, itching, and abdominal discomfort. It is essential to follow the prescribed dosage and duration of treatment as directed by a healthcare professional for optimal therapeutic outcomes.
